The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 381.00
Bid: 381.00
Ask: 385.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.05%)
Open: 365.00
High: 381.00
Low: 365.00
Prev. Close: 381.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Group CEO succession

7 Nov 2023 07:01

RNS Number : 5264S
Zotefoams PLC
07 November 2023
 

 

Zotefoams plc

('Zotefoams', the 'Company' or 'Group')

 

Group CEO succession

7 November 2023 - Zotefoams (LSE: ZTF), a world leader in cellular materials technology, announces that David Stirling has informed the Board of his intention to retire from his role as Group CEO and from the Board within the next 12 months. David will continue in his post until a successor is appointed and has committed to remaining available thereafter, to support and advise the business in executing an effective transition in the leadership of the Group. The Board has therefore commenced a formal succession process, supported by global organisational consulting firm Korn Ferry.

 

A director of Zotefoams for more than 26 years, David was appointed as Group CEO in May 2000. Under his leadership, the Group has been transformed into a global leader in specialist foam technologies, with a diverse customer base, product range and manufacturing operations in the UK, Europe, North America and Asia.

 

The Group's new CEO will join a strong executive leadership team with significant functional and market experience, gained from within and outside the business. The Board remains confident that the business remains well positioned to deliver long-term sustainable growth across an increasingly broad spectrum of end markets and geographies.

 

Dr Lynn Drummond, Chair of the Company, said: "David has made an enormous contribution to Zotefoams. The Board is committed to finding the right person to succeed him and we appreciate David's support in enabling us to manage this succession in the most effective way."

 

David Stirling, Group CEO, commented: "It has been a privilege and pleasure to lead the development of Zotefoams, which is now a multi-site global business. The time is now right for me to retire and for the business to plan my succession. Zotefoams will continue to receive my support and I will remain with the business to help with the transitional period as a new CEO is appointed."

 

There is no further information which would require disclosure under LR9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

 

Zotefoams plc

+44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

 

 

IFC Advisory

+44 (0) 203 934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

 

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA, Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSDFDMEDSEDF
Date   Source Headline
19th Apr 20247:00 amRNSExclusivity agreement with Design Blue Limited
19th Apr 20247:00 amRNS2023 Annual Report & Notice of 2024 AGM
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20248:36 amRNSReplacement Notice Transactions Of Directors/PDMRs
26th Mar 20247:00 amRNSGroup CEO succession
25th Mar 20245:58 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd Mar 20245:31 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSPreliminary Results
12th Mar 20241:41 pmRNSNotification Of Transactions Of Directors/PDMRs
14th Feb 20247:00 amRNSZotefoams joins independent authority, RECOUP
13th Feb 202412:31 pmRNSNotification Of Transactions Of Directors/PDMRs
7th Feb 20247:00 amRNSNotice of results and investor presentation
5th Feb 20241:20 pmRNSHolding(s) in Company
22nd Jan 20241:58 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSFull Year Trading Update
12th Jan 20245:13 pmRNSDirector/PDMR Shareholding
12th Jan 202412:28 pmRNSNotification Of Transactions Of Directors/PDMRs
5th Jan 202412:47 pmRNSReplacement Holding(s) in Company
4th Jan 20243:24 pmRNSHolding(s) in Company
4th Jan 20241:17 pmRNSHolding(s) in Company
13th Dec 20234:49 pmRNSHolding(s) in Company
13th Dec 20234:31 pmRNSReplacement Notice Transactions Of Directors/PDMRs
13th Dec 20231:54 pmRNSHolding(s) in Company
12th Dec 20233:46 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Dec 202312:45 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Dec 20231:53 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Nov 20237:00 amRNSTop industry award for ReZorce® beverage cartons
14th Nov 202311:56 amRNSNotification Of Transactions Of Directors/PDMRs
8th Nov 20235:38 pmRNSHolding(s) in Company
7th Nov 20237:01 amRNSGroup CEO succession
7th Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSZotefoams programme extension at Nike
12th Oct 202312:09 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Oct 20239:47 amRNSNotification Of Transactions Of Directors/PDMRs
29th Sep 20237:00 amRNSBoard Changes
18th Sep 20234:45 pmRNSHolding(s) in Company
12th Sep 202310:57 amRNSNotification Of Transactions Of Directors/PDMRs
5th Sep 20234:07 pmRNSHolding(s) in Company
31st Aug 20233:14 pmRNSHolding(s) in Company
29th Aug 20237:00 amRNSInvestor presentation on Investor Meet Company
25th Aug 20237:00 amRNSIssue of Equity
14th Aug 20231:51 pmRNSNotification of Transactions of Directors/PDMRs
9th Aug 20233:29 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSInterim Results
19th Jul 20231:29 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSJoint development agreement for ReZorce®
12th Jul 202311:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th Jul 20237:00 amRNSNotice of results and investor presentation
22nd Jun 20232:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.